Trial Profile
Rivaroxaban for Scheduled Work-up of Patients With Suspected Deep Venous Thrombosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Deep vein thrombosis
- Focus Adverse reactions
- 18 Jan 2019 Status changed from recruiting to completed.
- 29 Sep 2017 Planned End Date changed from 1 Feb 2018 to 1 Jun 2019.
- 29 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2018.